M1A.2390 Drug-induced chronic gout, unspecified wrist, without tophus (tophi)

Name of the Condition

• Drug-Induced Chronic Gout, Unspecified Wrist, Without Tophus (Tophi)

Summary

Drug-induced chronic gout, unspecified wrist, without tophus is a form of arthritis affecting the wrist joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms without the formation of tophi (urate crystal deposits) at the time of diagnosis.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the wrist joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

• Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
• Prolonged exposure to urate-raising drugs
• Pre-existing hyperuricemia or gout history
• Renal impairment affecting drug clearance

Symptoms

• Recurrent episodes of intense wrist pain, often with swelling and redness
• Persistent warmth and tenderness in the affected wrist
• Stiffness and limited range of motion in the wrist
• Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. A thorough medication history is critical to identify potential drug triggers. Laboratory tests typically include serum uric acid levels, while imaging (e.g., X-ray, ultrasound) may show joint inflammation or crystal deposits. Synovial fluid analysis can confirm the presence of urate crystals, though tophi are absent in this specific code.

Treatment Options

Treatment focuses on managing uric acid levels and reducing inflammation. This may include discontinuing or adjusting the causative medication, if possible, and initiating urate-lowering therapy (e.g., allopurinol, febuxostat). Nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids may be used to control acute flare-ups. Lifestyle modifications, such as dietary changes, may also be recommended.

Prognosis and Follow-Up

With appropriate management, symptoms can be controlled, and joint damage may be minimized. Regular follow-up is essential to monitor uric acid levels, adjust medications, and assess for complications. Long-term adherence to treatment is key to preventing recurrence and progression.

Complications

Untreated or poorly managed cases may lead to chronic joint damage, persistent pain, and reduced mobility. While tophi are not present in this code, untreated gout can progress to their formation over time.

Lifestyle & Prevention

• Avoid or limit medications known to raise uric acid levels, when feasible.
• Maintain a balanced diet low in purines (e.g., limit red meat, seafood, and alcohol).
• Stay hydrated to support uric acid excretion.
• Follow prescribed treatment plans consistently.

When to Seek Professional Help

Seek medical attention if you experience sudden, severe wrist pain, swelling, or redness, or if symptoms persist despite home care. Prompt evaluation is important to prevent joint damage and adjust treatment as needed.

Tips for Medical Coders

This code is specific to drug-induced chronic gout affecting the unspecified wrist without tophi. Ensure documentation confirms the absence of tophi and specifies the wrist as the affected site. Verify that the condition is chronic (not acute) and directly linked to medication use. Accurate coding requires clear clinical correlation between the drug exposure and the gout diagnosis.